Back
Arcturus Therapeutics Holdings Stock Predictions
Top investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
25
ARCT
Arcturus Therapeutics Holdings
Last Price:
$10.52
Seasonality Move:
23.58%
7 Day Trial
ALL ACCESS PASS
$
7
This tech company grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Arcturus Therapeutics Holdings Stock Forecast
-
Over the next 52 weeks, Arcturus Therapeutics Holdings has on average historically risen by 2.2% based on the past 11 years of stock performance.
-
Arcturus Therapeutics Holdings has risen higher in 5 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 45.45%
-
Is Arcturus Therapeutics Holdings Stock Undervalued?The current Arcturus Therapeutics Holdings [ARCT] share price is $10.53. The Score for ARCT is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
-
ARCT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Arcturus Therapeutics Holdings Stock Go Up Next Year?
-
Over the next 52 weeks, Arcturus Therapeutics Holdings has on average historically risen by 2.2% based on the past 11 years of stock performance.
Arcturus Therapeutics Holdings Stock Rating
Sell
25
Arcturus Therapeutics Holdings (ARCT)
is a Sell
Is Arcturus Therapeutics Holdings overpriced?
-
Arcturus Therapeutics Holdings has risen higher in 5 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 45.45%
Arcturus Therapeutics Holdings Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
arcturusrx.com
52-Week Data
52-Week High:
45.00
52-Week Low:
8.04
Prediction Charts
Market Cap:
285.6M
Price in USD:
10.53
Volume:
358.2K
Beta:
2.57
Technical Analysis
SMA50:
13.68
SMA100:
15.45
SMA200:
18.25
52-Wk Change:
-61.9%
Stock Predictions
-
Is Arcturus Therapeutics Holdings stock public?Yes, Arcturus Therapeutics Holdings is a publicly traded company.
-
What is the Arcturus Therapeutics Holdings stock quote today?The Arcturus Therapeutics Holdings stock price is 10.53 USD today.
-
How to buy Arcturus Therapeutics Holdings stock online?You can buy Arcturus Therapeutics Holdings shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Mar-31 | 11.06 | 10.59 | 11.24 | 10.35 |
| Apr-1 | 10.49 | 9.43 | 10.49 | 9.41 |
| Apr-2 | 9.23 | 10.20 | 10.26 | 9.23 |
| Apr-3 | 9.59 | 9.49 | 9.80 | 9.18 |
| Apr-4 | 9.12 | 9.11 | 9.35 | 8.70 |
| Apr-7 | 8.56 | 9.09 | 9.13 | 8.04 |
| Apr-8 | 9.17 | 8.91 | 9.46 | 8.70 |
| Apr-9 | 8.78 | 9.82 | 10.38 | 8.42 |
| Apr-10 | 9.50 | 9.35 | 9.53 | 8.68 |
| Apr-11 | 9.52 | 9.70 | 9.88 | 9.22 |
| Apr-14 | 9.93 | 10.18 | 10.33 | 9.50 |
| Apr-15 | 10.20 | 10.57 | 11.00 | 10.18 |
| Apr-16 | 10.49 | 10.30 | 10.61 | 10.07 |
| Apr-17 | 10.30 | 10.53 | 10.66 | 10.11 |
Arcturus Therapeutics Holdings Earnings
Arcturus Therapeutics Holdings Earnings Report: Per Share Arcturus Therapeutics Holdings Earnings Q1 Q2 Q3 and Q4 last year and next year.
Arcturus Therapeutics Holdings Forecast Revenue Growth
Arcturus Therapeutics Holdings Stock Analysis: Historical quarterly revenues per share for Arcturus Therapeutics Holdings and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.07 per share, a decrease this year of $2.67 per share, and an increase next year of $1.11 per share.
* Arcturus Therapeutics Holdings stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.